Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione
  • Business
  • Area funzionale Sort ascending
  • Data di pubblicazione
Titolo di lavoro Site Posizione Divisione Business Area funzionale Sort ascending Data di pubblicazione
QA Compliance Postgraduate Stein Aargau Svizzera Operations Innovative Medicines Others Ott 14, 2024
Lehrling Elektrotechnik Schaftenau Austria Operations Innovative Medicines Others Set 11, 2024
Lehre Labortechnik Schaftenau Austria Operations Innovative Medicines Others Set 11, 2024
Lehrling Mechatronik Schaftenau Austria Operations Innovative Medicines Others Set 11, 2024
Next Generation Scientist 2025 Basel (City) Svizzera Biomedical Research Innovative Medicines Others Ott 01, 2024
Long term Finance Internship İstanbul Kavacık Turchia Finance Innovative Medicines Others Set 10, 2024
Chef de Projet Omnicanal – Apprenti H/F Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Lug 04, 2024
Postdoc Patient-Centered Outcomes Basel (City) Svizzera Development Innovative Medicines Others Ott 09, 2024
Supply Chain Graduate Program Associate - UAE National Dubai Emirati Arabi Uniti Operations Innovative Medicines Others Ott 14, 2024
Legal Trainee - Legal Procurement, Data/Digital & IT Basel (City) Svizzera Legal CTS Others Ott 10, 2024
Legal Trainee - Novartis Operations Basel (City) Svizzera Operations CTS Others Ott 15, 2024
Digital Project Intern Rotkreuz (Office-Based) Svizzera International Innovative Medicines Others Ott 15, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 16, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) Francia Finance Innovative Medicines Others Mag 17, 2024
ALTERNANT Expert en développement des compétences Paris Headquarter (Novartis Pharma S.A.S.) Francia Innovative Medicines Others Mag 21, 2024
Alternant INGENIEUR DATA Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 23, 2024
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 28, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue Francia Operations Innovative Medicines Others Mag 31, 2024
APPRENTI(E) ANIMATEUR SSE (H/F) Huningue Francia Operations Innovative Medicines Others Giu 10, 2024
HR Data Analyst & Communication H/F en Alternance Paris Headquarter (Novartis Pharma S.A.S.) Francia People & Organization Innovative Medicines Others Lug 04, 2024
Analyst Stratégique H/F) en Stage Rueil-Malmaison Francia International Innovative Medicines Others Ago 19, 2024
Embrace Advisor Verona Field Force (Italy) Italia International Innovative Medicines Others Ott 16, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit e finanza Lug 22, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germania Finance Corporate Audit e finanza Ott 16, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit e finanza Lug 28, 2024
BPA Planning Process, RLT Baarle Nassau Paesi Bassi Finance Innovative Medicines Audit e finanza Ago 05, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit e finanza Set 13, 2024
Financial Control & Compliance (FC&C) Lead Amiria Egitto Finance CTS Audit e finanza Mag 23, 2024
Corporate Tax Manager Amiria Egitto Finance Corporate Audit e finanza Mag 31, 2024
Senior Accountant, Tax Shanghai (Shanghai) Cina Finance Corporate Audit e finanza Ago 29, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit e finanza Giu 05, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit e finanza Giu 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit e finanza Giu 13, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit e finanza Giu 20, 2024
FP&A Manager İstanbul Kavacık Turchia Finance Innovative Medicines Audit e finanza Giu 28, 2024
S2P Business Partner (Korean speaker) Selangor Malaysia Finance CTS Audit e finanza Set 24, 2024
Senior FRA Specialist GL Prague Repubblica Ceca Finance CTS Audit e finanza Set 26, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit e finanza Ott 04, 2024
R2R Lead Israel Israel Israele Finance CTS Audit e finanza Set 16, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit e finanza Set 17, 2024
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) Francia Finance CTS Audit e finanza Set 27, 2024
BPA & R2R Analyst Amsterdam Paesi Bassi Finance Innovative Medicines Audit e finanza Set 04, 2024
R2R Senior Specialist Bucuresti Romania Finance CTS Audit e finanza Set 05, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit e finanza Set 06, 2024
Revenue Deduction & Accounting Statutory Lead Warsaw Polonia Finance CTS Audit e finanza Ott 10, 2024
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit e finanza Ott 10, 2024
BPA (Budget & Planning Analyst) İstanbul Kurtköy Turchia Finance Innovative Medicines Audit e finanza Ott 10, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spagna Finance Corporate Audit e finanza Ott 01, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia